$GUER
Guerrilla RF Inc Stock $guer

$guer Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923023820 Filed on August 15, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$3.366M	$3.779M
YoY Change	51.67%	22.41%
Cost Of Revenue	$1.491M	$1.550M
YoY Change	56.79%	21.3%
Gross Profit	$1.875M	$2.229M
YoY Change	47.83%	23.2%
Gross Profit Margin	55.71%	58.99%
Selling, General & Admin	$2.827M	$3.007M
YoY Change	12.28%	23.6%
% of Gross Profit	150.76%	134.89%
Research & Development	$2.775M	$2.653M
YoY Change	32.33%	31.54%
% of Gross Profit	148.01%	119.0%
Depreciation & Amortization	$423.0K	$423.1K
YoY Change	13.41%	52.9%
% of Gross Profit	22.56%	18.98%
Operating Expenses	$5.602M	$5.660M
YoY Change	21.4%	27.19%
Operating Profit	-$3.727M	-$3.431M
YoY Change	11.38%	29.93%
Interest Expense	-$731.6K	-$389.0K
YoY Change	141.17%	449.04%
% of Operating Profit
Other Income/Expense, Net	-$753.7K	-$390.3K
YoY Change	134.52%	286.0%
Pretax Income	-$4.481M	-$3.821M
YoY Change	22.17%	39.37%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$4.500M	-$3.800M
YoY Change	21.62%	40.74%
Net Earnings / Revenue	-133.69%	-100.55%
Basic Earnings Per Share	-$0.62	-$0.56
Diluted Earnings Per Share	-$0.62	-$0.56
COMMON SHARES
Basic Shares Outstanding	6.827M	6.797M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$876.9K	$238.0K
YoY Change	-57.33%	-86.04%
Cash & Equivalents	$876.9K	$238.0K
Short-Term Investments
Other Short-Term Assets	$240.5K	$738.5K
YoY Change	-36.18%	-2.97%
Inventory	$1.904M	$1.778M
Prepaid Expenses	$240.5K	$738.5K
Receivables	$1.541M	$1.985M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.563M	$4.740M
YoY Change	-10.49%	-24.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.139M	$4.882M
YoY Change	-49.18%	0.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$224.7K	$197.1K
YoY Change
Total Long-Term Assets	$15.12M	$15.78M
YoY Change	80.86%	208.2%
TOTAL ASSETS
Total Short-Term Assets	$4.563M	$4.740M
Total Long-Term Assets	$15.12M	$15.78M
Total Assets	$19.69M	$20.52M
YoY Change	46.26%	79.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.582M	$2.466M
YoY Change	0.78%	28.43%
Accrued Expenses	$745.1K	$552.1K
YoY Change	512.88%	364.6%
Deferred Revenue
YoY Change
Short-Term Debt	$1.158M	$1.842M
YoY Change
Long-Term Debt Due	$8.820M	$1.125M
YoY Change	699.52%	57.77%
Total Short-Term Liabilities	$13.37M	$5.985M
YoY Change	233.83%	51.61%
LONG-TERM LIABILITIES
Long-Term Debt	$3.502M	$9.274M
YoY Change	-55.52%	228.76%
Other Long-Term Liabilities	$6.342M	$6.277M
YoY Change	6341.02%	4722.91%
Total Long-Term Liabilities	$9.844M	$15.55M
YoY Change	23.47%	426.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.37M	$5.985M
Total Long-Term Liabilities	$9.844M	$15.55M
Total Liabilities	$23.21M	$21.54M
YoY Change	93.8%	212.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.40M	-$34.90M
YoY Change	69.1%	77.16%
Common Stock	$789.00	$679.00
YoY Change	-76.36%	-79.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.524M	-$1.013M
YoY Change
Total Liabilities & Shareholders Equity	$19.69M	$20.52M
YoY Change	46.26%	79.61%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$4.500M	-$3.800M
YoY Change	21.62%	40.74%
Depreciation, Depletion And Amortization	$423.0K	$423.1K
YoY Change	13.41%	52.9%
Cash From Operating Activities	-$2.248M	-$3.095M
YoY Change	26.1%	75.11%
INVESTING ACTIVITIES
Capital Expenditures	$45.33K	-$24.66K
YoY Change	-96.49%	-83.24%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$45.33K	$24.66K
YoY Change	-96.49%	-116.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.933M	1.431M
YoY Change	-14.34%	39.09%
NET CHANGE
Cash From Operating Activities	-2.248M	-3.095M
Cash From Investing Activities	-45.33K	24.66K
Cash From Financing Activities	2.933M	1.431M
Net Change In Cash	638.9K	-1.640M
YoY Change	82.46%	85.07%
FREE CASH FLOW
Cash From Operating Activities	-$2.248M	-$3.095M
Capital Expenditures	$45.33K	-$24.66K
Free Cash Flow	-$2.294M	-$3.071M
YoY Change	-25.37%	89.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6825131
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6825131
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6211206
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6211206
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023Q2	guer	Common Stock Voting Rights Vote Per Share CommonStockVotingRightsVotePerShare	1	pure
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	631675	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1198516	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1100492	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1060299	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1076140	usd
CY2023Q2	guer	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	5986355	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11053477	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4224379	usd
CY2023Q2	guer	Operating Lease Liability Remainder Of Fiscal Year OperatingLeaseLiabilityRemainderOfFiscalYear	266209	usd
CY2023Q2	guer	Operating Lease Liability Year One OperatingLeaseLiabilityYearOne	512777	usd
CY2023Q2	guer	Operating Lease Liability Year Two OperatingLeaseLiabilityYearTwo	468349	usd
CY2023Q2	guer	Operating Lease Liability Year Three OperatingLeaseLiabilityYearThree	479478	usd
CY2023Q2	guer	Operating Lease Liability Year Four OperatingLeaseLiabilityYearFour	551585	usd
CY2023Q2	guer	Operating Lease Liability After Year Four OperatingLeaseLiabilityAfterYearFour	4550700	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6829098	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	676618	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1345332	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1024565	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	931779	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	137357	usd
CY2023Q2	guer	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	22944	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	4138595	usd
CY2023Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	477703	usd
CY2023Q2	guer	Finance Lease Liability Remainder Of Fiscal Year FinanceLeaseLiabilityRemainderOfFiscalYear	553180	usd
CY2023Q2	guer	Finance Lease Liability Year One FinanceLeaseLiabilityYearOne	1158803	usd
CY2023Q2	guer	Finance Lease Liability Year Two FinanceLeaseLiabilityYearTwo	912064	usd
CY2023Q2	guer	Finance Lease Liability Year Three FinanceLeaseLiabilityYearThree	883994	usd
CY2023Q2	guer	Finance Lease Liability Year Four FinanceLeaseLiabilityYearFour	131498	usd
CY2023Q2	guer	Finance Lease Liability After Year Four FinanceLeaseLiabilityAfterYearFour	21353	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	3660892	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56238
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3837067
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2000 Pisgah Church Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Greensboro
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27455
	dei	City Area Code CityAreaCode	336
	dei	Local Phone Number LocalPhoneNumber	510-7840
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6827185
CY2023Q2	us-gaap	Cash Cash	238006	usd
CY2022Q4	us-gaap	Cash Cash	4340407	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1985101	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1124971	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1778192	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672925	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	738530	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	643401	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	4739829	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7781704	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	0	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	3574746	usd
CY2023Q2	guer	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	197137	usd
CY2022Q4	guer	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	0	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10703546	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	209669	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	4882253	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	5098097	usd
CY2023Q2	us-gaap	Assets Assets	20522765	usd
CY2022Q4	us-gaap	Assets Assets	16664216	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2465949	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4466045	usd
CY2023Q2	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	1842202	usd
CY2022Q4	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	959803	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	552078	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	139794	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1125156	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1078506	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5985385	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6644148	usd
CY2023Q2	guer	Longterm Debt Noncurrent Excluding Longterm Notes Payable LongtermDebtNoncurrentExcludingLongtermNotesPayable	677300	usd
CY2022Q4	guer	Longterm Debt Noncurrent Excluding Longterm Notes Payable LongtermDebtNoncurrentExcludingLongtermNotesPayable	44279	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6277020	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71714	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2535736	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2984618	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	6060682	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4564564	usd
CY2023Q2	us-gaap	Liabilities Liabilities	21536123	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14309323	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	679	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	621	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33881631	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29427440	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34895668	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27073168	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1013358	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2354893	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20522765	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16664216	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3779334	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3087350	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7010222	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6953261	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1549881	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1277759	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2953226	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2825040	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	2229453	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1809591	usd
	us-gaap	Gross Profit GrossProfit	4056996	usd
	us-gaap	Gross Profit GrossProfit	4128221	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2652989	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2016934	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5239158	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3818940	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1629944	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1169435	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2991893	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2255278	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1377342	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1263730	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2923505	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2503380	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	5660275	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	4450099	usd
	us-gaap	Operating Expenses OperatingExpenses	11154556	usd
	us-gaap	Operating Expenses OperatingExpenses	8577598	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3430822	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2640508	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7097560	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4449377	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-389012	usd
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-70853	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-730869	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-128074	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1248	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-30251	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5929	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-30251	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-390260	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-101104	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-724940	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-158325	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3821082	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2741612	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7822500	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4607702	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6801929
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5539149
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6653213
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5538594
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2354893	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4001418	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3658675	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	268640	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2380790	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3821082	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	96757	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	330177	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1013358	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8915625	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1866090	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5232	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	32856	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7087623	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2741612	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	181302	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4527313	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7822500	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4607702	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	821374	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	527633	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	598817	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	214158	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	106157	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
	us-gaap	Accretion Expense AccretionExpense	67720	usd
	us-gaap	Accretion Expense AccretionExpense	0	usd
	guer	Shares Issued For Prepaid Services SharesIssuedForPrepaidServices	45833	usd
	guer	Shares Issued For Prepaid Services SharesIssuedForPrepaidServices	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	860130	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	303003	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	105267	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	430323	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-389091	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-426315	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1870167	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-24515	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-301541	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8930613	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4197437	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	93141	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	299608	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93141	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-299608	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	6365824	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1349935	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3755432	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5232	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	4289941	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	165265	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	543180	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	302112	usd
	guer	Repayment Of Finance Insurance Premiums Financing Activities RepaymentOfFinanceInsurancePremiumsFinancingActivities	291782	usd
	guer	Repayment Of Finance Insurance Premiums Financing Activities RepaymentOfFinanceInsurancePremiumsFinancingActivities	-0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	75000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4921353	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	887790	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4102401	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3609255	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4340407	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5313985	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	238006	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1704730	usd
	us-gaap	Stock Issued1 StockIssued1	100000	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	512389	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	3316038	usd
	guer	Financing Of Insurance Premium And Software FinancingOfInsurancePremiumAndSoftware	173360	usd
	guer	Financing Of Insurance Premium And Software FinancingOfInsurancePremiumAndSoftware	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7289971	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	guer	Financing Of Mask Set FinancingOfMaskSet	369421	usd
	guer	Financing Of Mask Set FinancingOfMaskSet	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	758194	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><em style="font: inherit;">1.</em> ORGANIZATION AND NATURE OF BUSINESS</b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;"><span style="background-color:#ffffff;">Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp., the “Company”) was incorporated in the State of Delaware on <em style="font: inherit;"> November 9, 2020. </em>On <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021,</em> the Company's wholly-owned subsidiary, Guerrilla RF Acquisition Corp., a corporation formed in the State of Delaware on <em style="font: inherit;"> October </em><em style="font: inherit;">20,</em> <em style="font: inherit;">2021</em> (“Acquisition Sub”) and privately held Guerrilla RF Operating Corporation (formerly known as Guerrilla RF, Inc.) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, on <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021</em> (the “Closing Date”), Acquisition Sub merged with and into Guerrilla RF Operating Corporation with Guerrilla RF Operating Corporation continuing as the surviving corporation and a wholly-owned subsidiary of the Company (the “Merger”). Prior to the Merger, Laffin Acquisition Corp. was a “shell” company registered under the Securities Exchange Act of <em style="font: inherit;">1934,</em> as amended (“the Exchange Act”), with <em style="font: inherit;">no</em> specific business plan or purpose until it began operating the business of Guerrilla RF Operating Corporation following the closing of the Merger. On <em style="font: inherit;"> May 30, 2023, </em>Guerrilla RF Operating Corporation was merged with and into the Company.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;"><span style="background-color:#ffffff;">All references in these unaudited interim condensed consolidated financial statements and related Quarterly Report to “Guerrilla RF” refer to: (i) for periods prior to <em style="font: inherit;"> May 30, 2023, </em>Guerrilla RF Operating Corporation; and (ii) for subsequent periods, Guerrilla RF, Inc. </span><span style="background-color:#ffffff;">Unless otherwise stated or the context otherwise indicates, references to the “Company”, “we”, “our”, “us” or similar terms refer to Guerrilla RF, Inc.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF designs and manufactures high‐performance Monolithic Microwave Integrated Circuits (MMICs) for the wireless infrastructure market. Guerrilla RF primarily focuses on researching and developing its existing products and building an infrastructure to handle a global distribution network; therefore, it has incurred significant start‐up losses. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Merger was accounted for as a “reverse acquisition” since, immediately following the consummation of the Merger, Guerrilla RF effectively controlled the Company. For accounting purposes, Guerrilla RF was deemed to be the accounting acquirer in the Merger and, consequently, the Merger is treated as a recapitalization of Guerrilla RF (i.e., a capital transaction involving the issuance of shares by the Company for the shares of Guerrilla RF). Accordingly, the assets, liabilities, and results of operations of Guerrilla RF became the historical consolidated financial statements of the Company, and the Company’s assets, liabilities, and results of operations were consolidated with Guerrilla RF beginning at the Closing Date. <em style="font: inherit;">No</em> step-up in basis or intangible assets or goodwill were recorded in the Merger.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Liquidity and Going Concern</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">In accordance with Financial Accounting Standards (“FASB”) Accounting Standards Update (“ASU”) <i><em style="font: inherit;">No.</em></i> <i><em style="font: inherit;">2014</em></i>-<i><em style="font: inherit;">15,</em> Disclosure of Uncertainties about an Entity</i>’<i>s Ability to Continue as a Going Concern (Subtopic</i> <i><em style="font: inherit;">205</em>-<em style="font: inherit;">40</em>)</i>, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within <em style="font: inherit;">one</em> year after the date that the unaudited interim condensed consolidated financial statements are issued. The accompanying unaudited interim condensed consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the ordinary course of business. The Company has historically financed its activities principally from common and preferred equity securities and debt issuances. <span style="background-color:#ffffff">The unaudited interim condensed consolidated financial statements do <em style="font: inherit;">not</em> include any adjustments relating to the recoverability of the recorded assets or the classification of liabilities that <em style="font: inherit;"> may </em>be necessary should the Company be unable to continue as a going concern.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"></p> <p style="font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Company has incurred substantial negative cash flows from operations in nearly every fiscal period since inception, </span><span style="font-family:"Times New Roman"; font-size:10pt"><span style="background-color:#ffffff;">including a </span></span><span style="font-family:"Times New Roman"; font-size:10pt"><span style="background-color:#ffffff;">net loss of $3.8 million for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> June 30, 2023</em></span></span><span style="background-color:#ffffff;">. In addition, as of <em style="font: inherit;"> June 30, 2023, </em>the Company had an accumulated deficit o</span><span style="font-family:"Times New Roman"; font-size:10pt"><span style="background-color:#ffffff;">f $34.9 million</span></span><span style="font-family:"Times New Roman"; font-size:10pt"><span style="background-color:#ffffff;">.</span></span><span style="background-color:#ffffff;"> The Company expects losses and negative cash flows to continue, primarily as a result of continued investment in research and development, capital additions supporting our planned business expansion and growth, sales and marketing efforts, </span>and increased administration expenses as our Company grows<span style="background-color:#ffffff">. </span>We plan to continue to invest in the implementation of our long-term strategic plan and we will require additional funding in <em style="font: inherit;">2023.</em> There is <em style="font: inherit;">no</em> assurance that appropriate funding will be available on terms, which are acceptable to us, or at all. This requirement for additional funding raises substantial doubt about our ability to continue as a going concern.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Company had a cash balance of $238 thousand at <em style="font: inherit;"> June 30, 2023. </em>In <em style="font: inherit;"> June 2022, </em>the Company established a loan facility with Spectrum Commercial Services Company, L.L.C. ("Spectrum") providing for advances of up to $3.0 million (the "Spectrum Loan Facility" further described in Note <em style="font: inherit;">5</em>). As of <em style="font: inherit;"> June 30, 2023, </em>the outstanding balance under the Spectrum Loan Facility was $1.5 million. In <em style="font: inherit;"> August </em><em style="font: inherit;">2022,</em> the Company established a loan facility with Salem Investment Partners V, Limited Partnership ("Salem") providing for advances of up to $8.0 million (the "Salem Loan Facility") further described in Note <em style="font: inherit;">5.</em> As of <em style="font: inherit;"> June 30, 2023, </em>the undiscounted outstanding balance under the Salem Loan Facility was $6.5 million. As discussed in Note <em style="font: inherit;">12,</em> subsequent to <em style="font: inherit;"> June 30, 2023, </em>the Company issued unsecured convertible promissory notes in the aggregate amount of $790,000 and drew down an additional <em style="font: inherit;">$1.5</em> million under the Salem Loan Facility. Furthermore, the Company is negotiating the advance of up to an additional $4.0 million under the Salem Loan Facility to fund future operations. Potentially, the Company could also draw down additional funds under the Spectrum Loan Facility; however, its ability to do so is dependent upon the value of eligible accounts receivable assigned to Spectrum as security for advances under the Spectrum Loan Facility, which value fluctuates from time to time and is ultimately outside of the Company’s control. The Company believes that its existing cash and cash equivalents, together with anticipated additional financing, will provide sufficient resources to support operations through end of the <em style="font: inherit;">first</em> quarter of <em style="font: inherit;">2024.</em> In the event the Company is unable to secure the $4.0 million additional financing or other funding sources, it <em style="font: inherit;"> may </em>be unable to fund ongoing operations and pay its obligations as they become due after the <em style="font: inherit;">third</em> quarter of <em style="font: inherit;">2023.</em></span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">In conjunction with the previously disclosed proposal to uplist to the Nasdaq or another national securities exchange, the Company’s board of directors approved a reverse split of shares of the Company’s common stock on a six-for-<em style="font: inherit;">one</em> basis, which was effective as of <em style="font: inherit;">12:01</em> a.m. Eastern Time on <em style="font: inherit;"> April 17, 2023 (</em>the “Effective Time”). As a result of the reverse stock split, at the Effective Time, every <em style="font: inherit;">six</em> shares of the issued and outstanding common stock were automatically converted into <em style="font: inherit;">one</em> share of common stock, but without any change in the par value per share. <em style="font: inherit;">No</em> fractional shares were issued as a result of the reverse stock split. Any fractional shares that would otherwise have resulted from the reverse stock split were rounded up to the next whole number. The number of authorized shares of common stock remains unchanged at 300,000,000 shares. Proportionate adjustments were made to the per share exercise price and the number of shares of common stock issuable upon the exercise of all outstanding stock options and warrants granted by the Company. The number of shares of common stock deliverable upon vesting of restricted stock units were similarly adjusted. Concurrently, the number of shares of common stock reserved for future issuance under the Company’s <em style="font: inherit;">2014</em> and <em style="font: inherit;">2021</em> Equity Incentive Plans immediately prior to the Effective Time were reduced proportionately.</span></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><span style="background-color:#ffffff;">Risks and Uncertainties</span></b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="background-color:#ffffff;">The Company is subject to several risks associated with companies at a similar stage, including dependence on key individuals, competition from similar products and larger companies, volatility of the industry, ability to obtain adequate financing to support growth, the ability to attract and retain additional qualified personnel to manage the anticipated growth of the Company, and general economic conditions including the current macro economic conditions impacting the banking and financial markets.</span></p>
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3800000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34900000	usd
CY2023Q2	us-gaap	Cash Cash	238000	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 0pt; text-align: justify;"></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-indent: 0pt; text-align: justify;"><b>Use of Estimates</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of our unaudited interim condensed consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and related disclosures. The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements, and reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments involve the identification of performance obligations in revenue recognition, the valuation of share-based compensation, and the valuation of equity financing, including the underlying fair value of the common stock. Accordingly, actual results could differ from those estimates.</p>
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6801929
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Concentrations of Credit Risk and Major Customers</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Financial instruments at <em style="font: inherit;"> June 30, 2023, </em>and <em style="font: inherit;"> December 31, 2022 </em>that potentially subject the Company to concentration of credit risk consist primarily of cash and accounts receivable. The Company’s cash is deposited with major financial institutions in the U.S. At times, deposits in financial institutions located in the U.S. <em style="font: inherit;"> may </em>be in excess of the amount of insurance provided on such deposits by the Federal Deposit Insurance Corporation (FDIC). To date, the Company has <em style="font: inherit;">not</em> experienced any losses on its cash deposits.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s accounts receivable are derived from revenue earned from customers located inside and outside of the U.S. Major customers are defined as those generating revenue in excess of <em style="font: inherit;">10%</em> of the Company’s aggregate annual revenue. The Company had <span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;"><span style="-sec-ix-hidden:c101960328"><span style="-sec-ix-hidden:c101960329">one</span></span> </span>major distributor customer, Richardson RFPD, Inc. ("RFPD") <span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;">accounti</span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">ng for </span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">82% and 83% of product shipment revenue</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> for the <em style="font: inherit;">six</em> months ended <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;">2022,</em> respectively. Accounts receivable from RFPD represented 81</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;">% and 76% of accounts receivable</span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> at <em style="font: inherit;"> June 30, 2023 </em>and <em style="font: inherit;"> December 31, </em><em style="font: inherit;">2</em></span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"><em style="font: inherit;">022,</em></span></span><span style="font-family: "Times New Roman"; font-size: 10pt;"><span style="background-color:#ffffff;"> r</span></span><span style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt;">espectively.</span></p>
CY2022Q4	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
CY2022	guer	Factoring Agreement Receivables Term Oustanding FactoringAgreementReceivablesTermOustanding	P90D
CY2022Q4	guer	Factoring Agreement Percentage Of Receivables Collateral FactoringAgreementPercentageOfReceivablesCollateral	0.15	pure
CY2022Q2	guer	Proceeds From Accounts Receivable Factoring ProceedsFromAccountsReceivableFactoring	3000000	usd
CY2023Q2	guer	Accounts Receivable Secured Debt Facility Receivables Assigned AccountsReceivableSecuredDebtFacilityReceivablesAssigned	1500000	usd
CY2023Q2	guer	Accounts Receivable Secured Debt Facility Amount Due AccountsReceivableSecuredDebtFacilityAmountDue	8000000.0	usd
	guer	Contract With Customer Liability Revenue To Be Recognized ContractWithCustomerLiabilityRevenueToBeRecognized	250000	usd
	guer	Contract With Customer Liability Revenue To Be Recognized ContractWithCustomerLiabilityRevenueToBeRecognized	0	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	6	pure
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5539149
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1630894
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	729393
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	512670	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	696409	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	37182	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	44037	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1228340	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	932479	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1778192	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672925	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8604558	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7999029	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3722305	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2900932	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4882253	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5098097	usd
	us-gaap	Depreciation Depreciation	821374	usd
	us-gaap	Depreciation Depreciation	527633	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	20000	usd
CY2023Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	10000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1698610	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	179087	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	155265	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	159952	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6358667	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	28603	usd
CY2023Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	8580184	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	769146
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	769146
CY2023Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	usd
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	94667
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	210000
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	4.20
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	9.42
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.52	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.67	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.52	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.67	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0334	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0250	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0334	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0292	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.18
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.64
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	459598	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	442522	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	601220
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.54
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	9333
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.97
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2863
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.41
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	607690
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.60
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M4D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3800
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.80
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	123
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.19
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	611367
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.64
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M4D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	506831
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.44
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2400000	usd
CY2023Q2	guer	Sharebased Payment Arrangement Granted Award Option Cost Not Yet Recognized Amount SharebasedPaymentArrangementGrantedAwardOptionCostNotYetRecognizedAmount	500000	usd
	guer	Sharebased Payment Arrangement Granted Award Cost Not Yet Recognized Period For Recognition SharebasedPaymentArrangementGrantedAwardCostNotYetRecognizedPeriodForRecognition	P2Y4M24D
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	598817000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	214158000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10703546	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	552078	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6277020	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6829098	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	3642843	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1125156	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2535736	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	3660892	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	728634	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	33257	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	630987	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	348141	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	135338	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	106279	usd
	guer	Finance Lease Cost FinanceLeaseCost	766325	usd
	guer	Finance Lease Cost FinanceLeaseCost	454420	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M6D
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M6D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1096	pure
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0724	pure
	us-gaap	Operating Lease Payments OperatingLeasePayments	980217	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	134321	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	543180	usd
CY2023Q2	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear	365466	usd
CY2023Q2	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year One LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearOne	685739	usd
CY2023Q2	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Two LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearTwo	632143	usd
CY2023Q2	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Three LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearThree	580821	usd
CY2023Q2	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Four LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearFour	524555	usd
CY2023Q2	guer	Lessee Operating Lease Liability Undiscounted Excess Amount After Year Four LesseeOperatingLeaseLiabilityUndiscountedExcessAmountAfterYearFour	1435655	usd
CY2023Q2	guer	Finance Lease Liability Undiscounted Excess Amount Remainder Of Fiscal Year FinanceLeaseLiabilityUndiscountedExcessAmountRemainderOfFiscalYear	123438	usd
CY2023Q2	guer	Finance Lease Liability Undiscounted Excess Amount Next Twelve Months FinanceLeaseLiabilityUndiscountedExcessAmountNextTwelveMonths	186529	usd
CY2023Q2	guer	Finance Lease Liability Undiscounted Excess Amount Year Two FinanceLeaseLiabilityUndiscountedExcessAmountYearTwo	112501	usd
CY2023Q2	guer	Finance Lease Liability Undiscounted Excess Amount Year Three FinanceLeaseLiabilityUndiscountedExcessAmountYearThree	47785	usd
CY2023Q2	guer	Finance Lease Liability Undiscounted Excess Amount Year Four FinanceLeaseLiabilityUndiscountedExcessAmountYearFour	5859	usd
CY2023Q2	guer	Finance Lease Liability Undiscounted Excess Amount After Year Four FinanceLeaseLiabilityUndiscountedExcessAmountAfterYearFour	1591	usd
CY2023Q1	guer	Lessee Operating Lease Lease Not Yet Commenced Annual Lease Expense LesseeOperatingLeaseLeaseNotYetCommencedAnnualLeaseExpense	1500000	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04	pure
CY2023Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	105284	usd
CY2022Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	83627	usd

Files In Submission

Name	View Source	Status
0001437749-23-023820-index-headers.html	Edgar Link	pending
0001437749-23-023820-index.html	Edgar Link	pending
0001437749-23-023820.txt	Edgar Link	pending
0001437749-23-023820-xbrl.zip	Edgar Link	pending
ex_535226.htm	Edgar Link	pending
ex_535227.htm	Edgar Link	pending
ex_535228.htm	Edgar Link	pending
ex_535229.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
guer-20230630.xsd	Edgar Link	pending
guer20230630_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
guer-20230630_cal.xml	Edgar Link	unprocessable
guer-20230630_lab.xml	Edgar Link	unprocessable
guer-20230630_pre.xml	Edgar Link	unprocessable
guer20230630_10q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
guer-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GUER
Guerrilla RF Inc Stock $guer

2023 Q3 Form 10-Q Financial Statement

#000143774923023820 Filed on August 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER Guerrilla RF Inc Stock $guer

2023 Q3 Form 10-Q Financial Statement

#000143774923023820 Filed on August 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER
Guerrilla RF Inc Stock $guer